Physician Wealth Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Physician Wealth Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$7.54K	Buy	1,900 +231	+14%	+$964	﹤0.01%	986
2026 Q2	$7.03K	Hold	1,669	–	–	﹤0.01%	972
2026 Q1	$5.86K	Hold	1,669	–	–	﹤0.01%	952
2025 Q4	$5.62K	Hold	1,669	–	–	﹤0.01%	944
2025 Q3	$2.19K	Hold	1,669	–	–	﹤0.01%	1185
2025 Q2	$1.2K	Buy	+1,669	New	+$1.31K	﹤0.01%	1277

Other funds holding IRWD

CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

SmartHarvest Portfolios Poulsbo, Washington $258M AUM 39.79% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Range Financial Group Tigard, Oregon $361M AUM 58.71% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Kathmere Capital Management Wayne, Pennsylvania $2.07B AUM 20.3% 1-Year Est. Return

Krilogy Financial St. Louis, Missouri $3.66B AUM 22.28% 1-Year Est. Return

Physician Wealth Advisors's IRWD Position: Q3 2026 in Review

Physician Wealth Advisors increased its Ironwood Pharmaceuticals (IRWD) stake by 14% in Q3 2026, buying an estimated $964 and bringing the position to 1,900 shares worth $7.54K. The position accounts for ﹤0.01% of the portfolio, ranked #986.

Physician Wealth Advisors first reported a position in IRWD in Q2 2025 and has held it in 6 quarters since. 36 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.

Physician Wealth Advisors held 1,900 shares of Ironwood Pharmaceuticals worth $7.54K as of Q3 2026.
Physician Wealth Advisors bought 231 Ironwood Pharmaceuticals shares in Q3 2026, an estimated $964.
Ironwood Pharmaceuticals made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q3 2026, its #986 holding.
Physician Wealth Advisors first reported a position in Ironwood Pharmaceuticals in Q2 2025 and has held it in 6 quarters since.
36 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.

Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.